Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- Check7 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA notice about NIH’s terminology transition appears on the page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.6%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe label 'Find Contact Information' was changed to 'Find contact information' to reflect a capitalization adjustment in the user interface. The revision line updated from v3.6.6 to v3.7.0, indicating a new software release.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page's version history now includes a new latest revision label, v3.6.6, and removes the prior label v3.6.5, indicating an update to the study record's revision history.SummaryDifference0.1%

- Check91 days agoChange DetectedThe revision entry was updated from v3.6.4 to v3.6.5 in the study record history, adding a new revision and replacing the previous one. This reflects an update to the record's revision metadata and does not alter the main content.SummaryDifference0.1%

Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.